17 employees
EnteroMedicsĀ® Inc. (NASDAQ: ETRM) is the developer of in-class weight loss treatments for obesity and obesity related risk factors.
2002
$6.3M
from 4 investors over 4 rounds
Enteromedics raised $6.3M on September 1, 2010
Investors: MPM Capital, Aberdare Ventures and Bay City Capital
Enteromedics raised undisclosed on July 1, 2004
Investors: Bay City Capital